Childhood Adrenocortical Tumours: a Review
Open Access
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 4 (2) , 81-9
Abstract
Childhood adrenocortical tumour (ACT) is not a common disease, but in southern Brazil the prevalence is 15 times higher than in other parts of the world. One hundred and thirty-seven patients have been identified and followed by our group over the past four decades. Affected children are predominantly girls, with a female-to-male ratio of 3.5:1 in patients below 4 years of age. Virilization alone (51.6%) or mixed with Cushing's syndrome (42.0%) was the predominant clinical picture observed in these patients. Tumours are unilateral, affecting both glands equally. TP53 R337H germline mutations underlie most childhood ACTs in southern Brazil. Epidemiological data from our casuistic studies revealed that this mutation has ~10% penetrance for ACT. Surgery is the definitive treatment, and a complete resection should always be attempted. Although adjuvant chemotherapy has shown some encouraging results, its influence on overall outcome is small. The survival rate is directly correlated to tumour size; patients with small, completely excised tumours have survival rates close to 90%, whereas in those patients with inoperable tumours and/or metastatic disease it is less than 10%. In the group of patients with large, excisable tumours, half of them have an intermediate outcome. Recent molecular biology techniques and genomic approaches may help us to better understand the pathogenesis of ACT, the risk of developing a tumour when TP53 R337H is present, and to predict its outcome. An ongoing pilot study consisting of close monitoring of healthy carriers of the TP53 R337H mutation - siblings and first-degree relatives of known affected cases - aims at the early detection of ACTs and an improvement of the cure rate.Keywords
This publication has 72 references indexed in Scilit:
- Mutation and methylation analysis of TP53 in adrenal carcinogenesisEuropean Journal of Surgical Oncology, 2005
- Adrenocortical Carcinoma: Prognostic Indices Based on Clinical and Immunohistochemical MarkersJournal of Pediatric Endocrinology and Metabolism, 2005
- Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor RegistryJournal of Clinical Oncology, 2004
- Adrenal Cortical Neoplasms in the Pediatric PopulationAmerican Journal of Surgical Pathology, 2003
- GermlineTP53 mutations and Li-Fraumeni syndromeHuman Mutation, 2003
- Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of DimersJournal of Biological Chemistry, 2002
- Relative frequency and morphology of cancers in carriers of germline TP53 mutationsOncogene, 2001
- An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinomaProceedings of the National Academy of Sciences, 2001
- Are There Low-Penetrance TP53 Alleles? Evidence from Childhood Adrenocortical TumorsThe American Journal of Human Genetics, 1999
- Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane TherapyNew England Journal of Medicine, 1990